Company news
Towa Pharmaceutical Co., Ltd. (TSE:4553) news
Every Towa Pharmaceutical Co., Ltd. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Towa Pharmaceutical : FY2026(1st quarter) Briefing Script and Q&A Summary of financial results meeting(319K／15P)
September 1, 2026
Consolidated Financial Results for the Three Months Ended June 30, 2026 (Based on Japanese GAAP)
August 6, 2026
Notice of Completion of Payment for the Issuance of 1st Series Class A Preferred Shares through Third-Party Allotment
July 31, 2026
Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation
July 10, 2026
Notice of Acquisition of Shares of Tanabe Pharma Factory Co., Ltd. and Transfer of Manufacturing and Marketing Approvals
July 3, 2026
Notice of Changes in Officers
June 24, 2026
Towa Pharmaceutical : FY2025 Briefing Script and Q&A Summary of financial results meeting(581K／27P)
June 16, 2026
Towa Pharmaceutical : FY2025 Supplementary Material of Financial Results(1.0M／46P)
May 14, 2026
Towa Pharmaceutical : FY2025 Consolidated Financial Results for the Year Ended March 31, 2026(Based on Japanese GAAP) (224K／22P)
May 14, 2026
Towa Pharmaceutical : FY2025(3rd quarter) Briefing Script and Q&A Summary of financial results meeting(296K／17P)
March 18, 2026
Towa Pharmaceutical : FY2025(3rd quarter) Supplementary Material of Financial Results(701K／24P)
February 13, 2026
Towa Pharmaceutical : FY2025(3rd quarter) Consolidated Financial Results for the Nine Months Ended December 31, 2025(Based on Japanese GAAP) (182K／13P)
February 13, 2026
Towa Pharmaceutical : FY2025(2nd quarter) Briefing Script and Q&A Summary of financial results meeting(297K／16P)
December 25, 2025
Towa Pharmaceutical : FY2025(2nd quarter) Supplementary Material of Financial Results(377K／26P)
November 10, 2025
Towa Pharmaceutical : FY2025(2nd quarter) Consolidated Financial Results for the Six Months Ended September 30, 2025(Based on Japanese GAAP) (403K／12P)
November 10, 2025
Towa Pharmaceutical : FY2025(1st quarter) Supplementary Material of Financial Results(922K／23P)
August 7, 2025
Towa Pharmaceutical : FY2025(1st quarter) Consolidated Financial Results for the Three Months Ended June 30, 2025(Based on Japanese GAAP) (311K／12P)
August 7, 2025
Towa Pharmaceutical : Notice of the 69th Ordinary General Meeting of Shareholders
May 29, 2025
Towa Pharmaceutical : FY2024 Supplementary Material of Financial Results (1.3M／44P)
May 15, 2025
Towa Pharmaceutical : FY2024(4th quarter) Consolidated Financial Results for the Year Ended March 31, 2025(Based on Japanese GAAP) (416K／18P)
May 15, 2025
Towa Pharmaceutical : FY2024(3rd quarter) Consolidated Financial Results for the Nine Months Ended December 31, 2024(Based on Japanese GAAP) (416K／13P)
February 13, 2025
Towa Pharmaceutical : FY2024(3rd quarter) Supplementary Material of Financial Results(994K／28P)
February 13, 2025
Towa Pharmaceutical : FY2024(2nd quarter) Supplementary Material of Financial Results(523K／36P)
November 12, 2024
Towa Pharmaceutical : FY2024(2nd quarter) Consolidated Financial Results for the Six Months Ended September 30, 2024(Based on Japanese GAAP) (467K／13P)
November 12, 2024
Towa Pharmaceutical : FY2023(1st quarter) Summary of Consolidated Financial Results for the Three Months Ended June 30, 2023(Based on Japanese GAAP) (375K/7P)
August 10, 2023
Towa Pharmaceutical : FY2023(1st quarter) Supplementary Material of Financial Results (1.03M/28P)
August 10, 2023
Towa Pharmaceutical : Notice of the 67th Ordinary General Meeting of Shareholders （176KB／10P）
May 30, 2023
Towa Pharmaceutical : FY2022 Supplementary Material of Financial Results (1.2M/42P)
May 15, 2023
Towa Pharmaceutical : FY2022(4th quarter) Summary of Consolidated Financial Results for the Year Ended March 31, 2023(Based on Japanese GAAP) (616K/10P)
May 15, 2023
Towa Pharmaceutical : Breckenridge Pharmaceutical, Inc. - Towa completes acquisition of Esteve's Generic Division
February 3, 2020